Clinical Policies

Collaborative Policy for Defining the boundaries between the NHS and Private Treatments and supplementary documentation

Collaborative Policy for Orphan Drugs

Collaborative Policy statement for Experimental and Unproven Treatments

Collaborative Policy for in year service developments and the PCT approach to treatments not yet assessed and prioritised

Collaborative Policy for Ongoing access to treatment following completion of NHS Commissioner funded Trials

Collaborative Policy for patients seeking funded hospital treatment in the European Union, European Economic Area or Switzerland

Collaborative Policy for Article 56 and S2

Collaborative Policy for Choice

Collaborative Policy for ongoing access to treatment following a trial of treatment which has not been sanctioned by the responsible PCT for treatment not routinely funded or which has not been formally assessed and prioritised

Collaborative Policy for patients changing responsible commissioner

Collaborative Policy for ongoing access to treatment following completion of non-commercially funded trials

Collaborative Policy for prior approval

Collaborative Policy on the use of cost effectiveness, value for money and cost effectiveness thresholds

Collaborative Policy and guidance for NICE

Collaborative policy for the use of Sativex in the treatment of spasticity associated with multiple sclerosis (MS)

Sacral Berve Stimulation (SNS) for Urinary Incontinence (UI) in Adult Women

Collaborative Policy for Orthotic Functional Electrical Stimulation (FES) for 'drop foot' of neurological origin

Policy for Continuing Healthcare Settings of Care

Collaborative Policy for Treatment Indications for Hyperbaric Oxygen therapy (HBOT) in Adults

Policy for Surrogacy

Collaborative EMSCG Definitions

Collaborative EMSCG Key Principles

Collaborative EMSCG Guidance Notes for Access to funding following third party funded treatment

Collaborative EMSCG Guidance Notes for the role of commissioners in the evaluation of individual treatments and the funding of clinical research

Collaborative Policy for Regional Secondary Fertility

Policy for Homeopathy

Policy for QIPP / Right Care Planned Care First Wave